top of page

BDTX

Black Diamond Therapy Inc.

Price

chg

chg neg

quotes and stock data may be delayed 15 minutes

 My Notes

Only BPIQ Pro members can create company notes. Learn more here.

52 wk low

low api

52 wk hi

high api

Cash

$179.7M

Burn Rate (Qtr)

$28.6M

Mkt Cap

mkt cap api

Avg Volume

volume api

*cash/burn updated:

Q1 '22

Drug Pipeline

Click the button to see the updated pipeline

No drug found

We don't have any drug data for this company yet

Drug | Disease (links)

Stage (next event)

Catalyst Date

Drug Name

Indication

Phase

Event

Exp Date

A free account is required to see the catalyst dates, notes, and more!

Loading Catalysts...

search in progress

Pipeline powered by

BDTX

BPIQ_Logo_RGB-01.jpg

Company Profile

Black Diamond targets undrugged mutations in patients with genetically defined cancers for whom limited treatment options currently exist. Black Diamond is built upon a deep understanding of cancer genetics, protein structure and function, and medicinal chemistry.

Recent Posts

See what the community is saying - click to see full post.

11 smid-cap cancer companies with huge readouts in September 2024

11 smid-cap cancer companies with huge readouts in September 2024

More Biopharma Stock Ideas from Q3 Hedge Fund Activity

More Biopharma Stock Ideas from Q3 Hedge Fund Activity

J.P. Morgan Healthcare Conference

ASCO 2021 Investor Hub - Presented Posters

bottom of page